CURRENT MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE:THERAPEUTIC APPROACHES AND NEW PERSPECTIVES
DOI:
https://doi.org/10.51473/rcmos.v1i1.2024.616Keywords:
Bronchodilators. COPD. Inhaled Corticosteroids. Multidisciplinary Approach. Pulmonary Rehabilitation.Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent chronic respiratory
condition characterized by progressive and irreversible airflow limitation. It is associated with
significant morbidity, with frequent exacerbations that increase hospitalization rates and
worsen patients' quality of life. This study reviews the latest therapeutic approaches in COPD
management, including pharmacological interventions such as long-acting bronchodilators,
inhaled corticosteroids, and biological agents, as well as non-pharmacological strategies such
as smoking cessation and pulmonary rehabilitation. Following an initial search of 6,973
studies, 32 articles were reviewed, leading to the inclusion of 9 key studies. The results
indicate that personalized treatment, combining medications and behavioral interventions,
improves lung function and reduces exacerbations. Interventions such as short-duration
antibiotic and systemic corticosteroid regimens proved effective in managing acute
exacerbations, while the use of non-invasive ventilation during the COVID-19 pandemic was
shown to be a viable alternative for COPD patients. It is concluded that COPD management
requires a multidisciplinary and personalized approach to optimize disease control and reduce
long-term complications.
Downloads
References
AL WACHAMI, N et al. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a
systematic review and meta-analysis. BMC Public Health, v.24, p.297, 2024.
ARCHONTAKIS BARAKAKIS, P et al. High versus Medium Dose of Inhaled Corticosteroid in Chronic
Obstructive Lung Disease: A Systematic Review and Meta-Analysis. Int J Chron Obstruct Pulmon Dis, v.18,
p.469-482, 2023.
HAN, M et al. The effectiveness of theory-based smoking cessation interventions in patients with chronic
obstructive pulmonary disease: a meta-analysis. BMC Public Health, v.23, p.1510, 2023.
KARAGIANNIS, C et al. The effects of upper limb exercise training on upper limb muscle strength in people
with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled
trials. Ther Adv Respir Dis, v.17, p.17534666231170813, 2023.
MESSOUS, S et al. Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a
randomized controlled trial. Ther Adv Respir Dis, v.16, p.17534666221099729, 2022.
PAPI, A et al. N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic
Bronchitis/Pre-COPD: Distinct Meta-analyses. Arch Bronconeumol, v.60, p.269-278, 2024.
SINGH, D. Pharmacological treatment of stable chronic obstructive pulmonary disease. Respirology, v.26,
p.643-651, 2021.
WU, TT et al. Real-World COPD Management Over 3 Years at the Community Health Service Center of
Shanghai During the COVID-19 Pandemic in China. Int J Chron Obstruct Pulmon Dis, v.18, p.349-364, 2023.
ZHAO, Z et al. Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD:
A systematic review and meta-analysis. PLoS One, v.18, p.e0296470, 2023.
Downloads
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Pedro Raydan Brandão Simões, Amanda Saori Fukushima, Davi Rezende Ribeiro, João Ricardo Buchemi de Carvalho (Autor/in)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This means you are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The use of this material is conditioned upon proper attribution to the original author(s), providing a link to the license, and indicating if changes were made. The license does not require permission from the author or the publisher as long as these conditions are met.
The Creative Commons license logo is displayed permanently in the footer of the journal.
The copyright of the manuscript can be retained by the authors without restrictions and can be requested at any time, even after publication in the journal.
How to Cite
